The maintenance of appropriate glucose levels is necessary for survival. Within the brain, specialized neurons detect glucose fluctuations and alter their electrical activity. These glucose-sensing cells include hypothalamic arcuate nucleus neurons expressing neuropeptide Y (NPY) and lateral hypothalamic area (LHA) neurons expressing orexin/hypocretins (ORX) or melanin-concentrating hormone (MCH). Within the LHA, a population of NPY-expressing cells exists; however, their ability to monitor energy status is unknown. We investigated whether NPY neurons located in the LHA, a classic hunger center, detect and respond to fluctuations in glucose availability and compared these responses with those of known LHA glucose sensors expressing ORX or MCH. Using mice expressing green fluorescent protein under the control of NPY regulatory elements, we identified LHA NPY cells and explored their anatomical distribution, neurochemical and electrical properties, in vivo responses to fasting and insulin-induced hypoglycemia, and in situ electrical responses to extracellular glucose. We report that NPY, ORX, and MCH are expressed in nonoverlapping populations within the LHA. Subpopulations of LHA NPY neurons were activated in vivo by both a 6-h fast and insulin-induced hypoglycemia. Likewise, increased extracellular glucose suppressed the electrical activity of approximately 70% of LHA NPY neurons in situ, eliciting hyperpolarization and activating background K ϩ currents. Furthermore, we report that the glucose sen- T he maintenance of appropriate levels of glucose, as a primary fuel source, is required for survival. To protect health and viability, central and peripheral mechanisms are in place to detect low and high levels of glucose, which then trigger adaptive changes in hormone release, brain function, and feeding behavior. Brain glucose-sensing neurons were first reported approximately 50 yr ago and are categorized as glucose inhibited (GI; cells decrease their electrical activity in response to increased glucose concentration) or glucose excited (GE; cells increase their electrical activity in response to increased glucose concentration) (1-4). Many of the cells identified thus far to sense glucose also express neuropeptide(s) intimately involved in arousal and energy balance. Within the lateral hypothalamic area (LHA), neurons expressing the wake-promoting peptides orexins/hypocretins (ORX) are GI, whereas neurons expressing the sleep-promoting neuropeptide melanin-concentrating hormone (MCH) are GE (2, 5). Despite evidence that another distinct population of GI cells may exist in the LHA (6), the chemical identity and characterization of this population has not yet been described.
T
he maintenance of appropriate levels of glucose, as a primary fuel source, is required for survival. To protect health and viability, central and peripheral mechanisms are in place to detect low and high levels of glucose, which then trigger adaptive changes in hormone release, brain function, and feeding behavior. Brain glucose-sensing neurons were first reported approximately 50 yr ago and are categorized as glucose inhibited (GI; cells decrease their electrical activity in response to increased glucose concentration) or glucose excited (GE; cells increase their electrical activity in response to increased glucose concentration) (1) (2) (3) (4) . Many of the cells identified thus far to sense glucose also express neuropeptide(s) intimately involved in arousal and energy balance. Within the lateral hypothalamic area (LHA), neurons expressing the wake-promoting peptides orexins/hypocretins (ORX) are GI, whereas neurons expressing the sleep-promoting neuropeptide melanin-concentrating hormone (MCH) are GE (2, 5) . Despite evidence that another distinct population of GI cells may exist in the LHA (6), the chemical identity and characterization of this population has not yet been described.
Neuropeptide Y (NPY) is a 36-amino acid peptide neurotransmitter in the pancreatic polypeptide family (7) . Within the brain, NPY is expressed in multiple regions including the LHA and is implicated in numerous physi-ological processes including energy homeostasis (8) . With relevance to energy balance, NPY is a potent orexigenic factor (9 -11) . In particular, NPY cells in the hypothalamic arcuate nucleus (ARC) project to the LHA (12, 13) and are crucial for feeding (14) , and a subpopulation of ARC NPY cells are GI (15, 16) . Also in the ARC is a key population of GE neurons that express proopiomelanocortin (4) .
Recently a number of reports examining the contribution of non-ARC-derived hypothalamic NPY to energy balance have been published (17) (18) (19) , highlighting the importance of NPY in the appropriate control of energy homeostasis. Although NPY cell bodies exist within the LHA, a brain region implicated in the control of energy balance (20) , this specific population of cells has not been extensively studied, and their properties and regulation by body energy levels are unknown. Here we aimed to determine whether LHA NPY neurons are sensitive to energy status and fluctuations in glucose availability and whether these cells represent a novel population or comprise a subset of the previously described LHA glucose-sensing neurons.
Materials and Methods

Animals
Transgenic mice on a C57BL/6 background expressing tau sapphire green fluorescent protein (GFP) under the control of NPY regulatory elements (21) (NPY-GFP mice; generous gift from Dr. Jeffrey Friedman, Rockefeller University, New York, NY) and wild-type C57BL/6 mice were group housed and maintained on a 12-h light, 12-h dark cycle (lights on at 0600 h) with ad libitum access to chow diet and water unless otherwise stated. All experiments were in accordance with the United Kingdom Animals (Scientific Procedures) Act 1986.
Acute insulin-induced hypoglycemia
To prevent basal alterations in blood glucose between animals, mice were assessed in the light cycle when they are normally less active. Food was removed at 0800 h and adult male NPY-GFP mice were treated at 1400 h with an ip dose of insulin 1.5 U/kg to induce hypoglycemia (n ϭ 6) or 0.9% saline (n ϭ 6). Tail vein blood glucose was measured via a glucometer immediately before dosing and every 30 min thereafter for 60 -90 min. After this, mice were deeply anesthetized, perfused with saline and then fixative, and brains extracted and prepared for immunohistochemical analysis as described below.
Acute food deprivation
Male (n ϭ 8) and female (n ϭ 8) adult NPY-GFP mice underwent a sex-and time-matched fed or fasted protocol. Fasted mice were food deprived for 6 h from 1600 h, encompassing 2 h before and 4 h after the onset of the dark cycle. Tail vein blood glucose was measured by glucometer at the start of the procedure at time 0 and 2, 3, 4, and 6 h later in ad libitum-fed and 6-h fasted mice.
A separate cohort of eight adult male NPY-GFP mice underwent the same ad libitum-fed or 6-h fasted protocol without blood sampling (n ϭ 4 per group). Four hours into the dark phase (2200 h), mice were deeply anesthetized and brains were extracted, submerged in fixative, and prepared for immunohistochemical analysis as described below.
In situ hybridization histochemistry (ISHH) and immunohistochemistry (IHC)
Mice were anesthetized with ketamine (100 mg/kg, ip) and xylazine (20 mg/kg, ip), and transcardially perfused with diethylpyrocarbonate-treated 0.9% saline followed by phosphatebuffed 10% formalin. Brains were removed, postfixed for 4 h, and then submerged overnight in 30% sucrose in diethylpyrocarbonate-treated PBS. Brains were cut on a freezing sliding microtome at 25 m (collected in 1:5 equal series).
NPY riboprobe generation and subsequent free-floating in situ hybridization was performed as previously described (22) . After hybridization, tissue was processed for detection of GFP immunoreactivity (IR) by IHC.
Chromagenic and fluorescent IHC was performed as previously described (23) . Primary antibodies used were rabbit anticFOS (1:10,000; Merck Chemicals, Nottingham, UK), rabbit anti-MCH and rabbit antiorexin-A (both 1:1,000; Phoenix Pharmaceuticals Europe, Karlsruhe, Germany), and goat anti-GFP (1:1,000; Abcam, Cambridge, UK). Secondary antibodies were either biotinylated (Jackson ImmunoResearch Europe, Newmarket, UK) or fluorophore conjugated (Molecular Probes, Eugene, OR). Chromagenic signal detection was achieved with an amplification step (Vectorstain Elite; Vector Laboratories, Peterborough, UK) and diaminobenzidine (Vector Laboratories).
LHA analysis was performed using a Zeiss Axioskop II (Carl Zeiss, Welwyn Garden City, UK) or Olympus BX61WI microscope (Olympus UK, Southend-on-Sea, UK) with attached charge-coupled device camera. Bregma levels were assigned using information from the publication, The Mouse Brain In Stereotaxic Coordinates (24) and digital images captured using Axiovision 4.3 software (Carl Zeiss) or Fluoview 2.1b (Olympus UK). Images were merged (where appropriate) using Adobe Photoshop CS3 (Adobe Systems Inc., San Jose, CA). Coexpression in dual-labeled cells was determined manually.
Electrophysiology
Standard current and voltage clamp whole-cell patch clamp electrophysiology was performed on male and female wild-type (14 -25 d, n ϭ 10) and NPY-GFP mice (12-30 d; n ϭ 8) as previously described (25) . Briefly, coronal brain slices (250 m thick) containing the LHA were cut and maintained in oxygenated artificial cerebrospinal fluid containing 1 mM glucose except where indicated. GFP-expressing neurons in live slices were identified by epifluorescence using an Olympus BX50WI microscope equipped with filter block and mercury bulb light source. Recordings were made at 30 -31 C with K-gluconate based pipette solutions as previously described (25) . Junction potential error was estimated to be ϩ10 mV and subtracted from voltage-clamp measurements. Input resistance was calculated from the slope of membrane current-voltage relationship between Ϫ80 and Ϫ60 mV. To examine whether the effects of glucose are mediated directly or via presynaptic input, one group of recordings was performed in the presence of tetrodotoxin. Some cells were also filled with biocytin to allow subsequent determination of cellular morphology or post-recording IHC for ORX or MCH as previously described (2) .
Data analysis
Data were analyzed with a t test, one-way ANOVA, or repeated-measures ANOVA, followed by Tukey's post hoc tests, where appropriate. For all analyses, significance was assigned at the P Յ 0.05 level. All data are presented as mean Ϯ SEM.
Results
LHA NPY GFP-labeled neurons express NPY mRNA
To investigate whether LHA NPY neurons respond to glucose, we used a NPY-GFP mouse line to facilitate the identification of NPY mRNA-expressing cells. Consistent with previous reports in rats (8) , we detected endogenous NPY mRNA in the LHA. This endogenous NPY mRNA expression pattern was comparable with the distribution of GFP-IR in NPY-GFP mice (Fig. 1, A-D) . To confirm exclusive expression of GFP in NPY mRNA-containing neurons within the LHA, dual-label ISHH/IHC was performed. We determined that, within the LHA, approximately half of NPY mRNA-expressing cells expressed GFP, whereas more than 95% of GFP-labeled cells coexpressed NPY mRNA (Fig. 1, C and D) . These data indicate that GFP expression is eutopic in the LHA and confirm the validity of the NPY-GFP reporter line for assessing LHA NPY cell function.
LHA NPY cells are distinct from classic LHA glucosensors expressing ORX and MCH
The LHA is known to contain two distinct, nonoverlapping populations of glucose-sensing cells expressing ORX or MCH (2, 12, 13) . To investigate whether LHA NPY is coexpressed with ORX or MCH, dual-label IHC was performed in NPY-GFP mice (n ϭ 3). GFP was not coexpressed with either MCH (Fig. 1, E and F) or ORX (Fig. 1, G and H) . These findings suggest that NPY, ORX, and MCH are expressed in distinct populations of LHA neurons.
Insulin-induced hypoglycemia activates LHA NPY cells in vivo
We next investigated whether LHA NPY neurons respond to changes in endogenous glucose levels. Hypoglycemia was elicited with a bolus of insulin (1.5 U/kg) and compared with saline vehicle treatment in NPY-GFP mice. Basal blood glucose levels between treatment groups were similar ( Fig. 2A ; vehicle 8.7 Ϯ 0.5 mM; insulin 8.3 Ϯ 0.6 mM; P Ͼ 0.05, n ϭ 6 per group). In the insulin-treated group, hypoglycemia (Ͻ3 mM glucose) was detected after 60 min and persisted until the termination of the procedure ( Fig. 2A ; vehicle 10.1 Ϯ 0.6 mM; insulin 2.0 Ϯ 0.3 mM; P Յ 0.001). Within the LHA, insulin-induced hypoglycemia significantly increased FOS-IR in GFP-IR cells ( Fig. 2B ; P Յ 0.001), indicating that a subpopulation of NPY neurons are activated by insulin-induced hypoglycemia.
To determine whether the observed responses to insulin-induced hypoglycemia in vivo could be explained by direct action of insulin on LHA NPY neurons, we recorded, in situ, the electrical responses of LHA NPY neu- 
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rons to bath-applied insulin (200 nM) in the presence of 1 M tetrodotoxin using whole-cell patch clamp electrophysiology. There was no significant effect of insulin on membrane potential ( Fig. 2G ; 0.21 Ϯ 0.51 mV depolarization; P Ͼ 0.05, n ϭ 9), indicating that LHA NPY neurons do not directly respond to insulin.
Acute food deprivation lowers blood glucose and activates LHA NPY cells in vivo
To determine whether LHA NPY cells are sensitive to physiological hypoglycemia, we first confirmed that acute 6 h food deprivation at the end of the light phase (2 h) and beginning of the dark phase (4 h) lowered blood glucose. We observed that food-deprived mice demonstrated significantly lower blood glucose compared with ad libitumfed controls ( Fig. 3A; 6 h fasted 5.71 Ϯ 0.18 mM; fed postprandial blood glucose 13.15 Ϯ 0.62 mM; P Յ 0.001, n ϭ 8 per group).
In a separate group of NPY-GFP mice, we next investigated whether physiological fasting-induced hypoglycemia influenced the activity of LHA NPY neurons. Compared with ad libitum fed controls, 6 h food deprivation significantly increased FOS-IR in LHA GFP-IR cells (Fig.  3 , B-F; P Յ 0.01). These data indicate that a subset of LHA NPY neurons is responsive to physiologically relevant fluctuations in energy state.
Membrane properties of LHA NPY neurons in situ
To explore functional properties and glucose responses of individual LHA NPY neurons, we recorded their elec- trical activity using whole-cell patch clamp electrophysiology in acute mouse brain slices, combined with biocytin filling to visualize cell morphology. Glucose concentrations used in situ (1-5 mM) were consistent with those found in blood in vivo after 6 h food restriction (blood glucose 5.71 Ϯ 0.18 mM) and in time-matched ad libitumfed controls (blood glucose 13.15 Ϯ 0.62 mM) (Fig. 3A) . Moreover, concentrations were also consistent with those reported in the LHA in vivo (26) and in other recent studies of hypothalamic glucosensing in vitro (2, 4, 5, 25) . Under baseline conditions (1 mM extracellular glucose), approximately 60% (10 of 17 cells) of NPY cells fired spontaneous actions potentials with a frequency of 4.8 Ϯ 2.0 Hz (Fig. 4A) . In turn, approximately 40% (seven of 17 cells) were electrically silent with resting membrane potentials of Ϫ48.5 Ϯ 3.0 mV ( 
Glucose responses of LHA NPY neurons in situ
In the presence of 1 M tetrodotoxin, glucose still hyperpolarized 75% (six of eight cells) of LHA NPY cells, suggesting a postsynaptic action ( Fig. 5B; 13 .0 Ϯ 1.6 mV hyperpolarization; P Յ 0.001, n ϭ 6). In these cells, the net glucose-activated current [measured using voltage-clamp ramps as in our previous studies (25) ] had a reversal potential of Ϫ95.1 Ϯ 1.8 mV ( Fig. 5C ; n ϭ 6), suggesting a high selectivity for K ϩ ions (E K ϭ Ϫ101 mV with our solutions). To compare the glucose sensitivity of LHA NPY neurons to that of known LHA glucosensors, namely ORX and MCH cells, we compared glucose-induced changes in membrane potential measured in the presence of 1 M tetrodotoxin (Fig. 5D ). In these experiments, NPY cells (n ϭ 6) were identified by GFP expression before recordings, whereas ORX (n ϭ 14) and MCH (n ϭ 14) cells were identified by postrecording immunostaining. This revealed that LHA NPY neurons show significantly different glucose sensitivity from ORX or MCH neurons ( Fig. 5D ; P Յ 0.001).
Discussion
The data presented here advance the understanding of the neurochemical and physiological identity of LHA glucosesensing neurons. Although such cells were first described several decades ago (1, 3) , their identities began to be clarified only very recently, with reports of ORX expression in GI cells, and MCH expression in GE cells (2, 5, 27) . Moreover, an intriguing report identified a subpopulation of LHA GI neurons that are ORX negative (6), but their chemical identity and their mechanism of inhibition by glucose remained to be clarified. The data reported here indicate that NPY-expressing LHA cells, which are distinct from ORX and MCH cells, act as sensors of body energy levels in vivo and are inhibited by glucose in situ. Interestingly, under baseline in situ conditions (1 mM glucose), we detected a greater proportion of spontaneously active LHA NPY cells (defined as generating spontaneous action potentials) than we observed in vivo (defined as expressing FOS-IR) following either insulin-induced hypoglycemia or a 6-h fast. A plausible explanation for the differences in percent of NPY-GFP neuron activation in vitro and in vivo is methodological. The electrophysiological experiments investigated the effect of glucose on individual neurons, whereas in vivo experiments were a snapshot of all LHA NPY-GFP neuron activity at a particular time point using immunohistochemistry to detect the indirect marker of neuronal activity, the immediate early gene c-fos. Moreover, the in vivo experiments investigated the effect of fluctuations of glucose within an intact system. It is therefore possible that inhibitory presynaptic signaling pathways influenced the activity of NPY-GFP neurons in vivo, inputs that were compromised in vitro. Alternatively, the in vivo increase in FOS-IR in NPY-GFP neurons may be an indirect effect caused by glucose and/or insulin activity at neurons providing synaptic first-or other-order interactions with LHA NPY neurons.
Although it is likely that LHA NPY neurons may also be modulated indirectly, our data suggest that glucose is capable of directly inhibiting LHA NPY neurons through a mechanism involving membrane hyperpolarization and opening of background K ϩ channels in the cell membrane.
A similar glucose-sensing mechanism has been recently reported in ORX cells (25) and ventromedial hypothalamic neurons (28) . Although the molecular steps involved remain to be determined (discussed in Refs. 25 and 29), our results support the idea that glucose-stimulated K ϩ channels play a wider role in brain function than originally anticipated (25) . The quantitative comparison of direct glucose responses of the three neurochemically distinct classes of LHA neurons (Fig. 5D) indicate that NPY cells display a glucose sensitivity that is significantly different from ORX and MCH cells (i.e. larger than MCH cells, smaller than ORX cells). This may suggest that LHA NPY, ORX, and MCH cells could be involved in different aspects of glucose homeostasis.
Recent data demonstrating a role for dorsomedial hypothalamic nucleus NPY neurons in glucose homeostasis and energy balance (18, 19) highlight the increasing understanding of the importance of non-ARC NPY neurons in energy homeostasis. Given the paucity of data related to NPY LHA neurons in the literature, it has not yet been clarified where these neurons project or the inputs they receive. However, it has been reported that NPY action within the LHA is orexigenic (10) , and overexpression of NPY within the LHA promotes hyperphagia, obesity, decreased dark cycle core temperature, and decreased locomotor activity (30) .
In summary, the data presented here characterize a population of NPY neurons that have not been well described and reveal a novel central neurocircuit that integrates information about glucose homeostasis in a way that is neurochemically and electrophysiologically distinct from known LHA glucose sensors.
